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Coexistence of neoplasms is an exceptional 
phenomenon, yet already described with LCH [1].  
Some studies suggest a 0.3% rate of occurrence of 
the association, whether meta- or synchronous, of 
LCH with Hodgkin lymphoma, which can be 
considered significant regarding the low incidence of 
both diseases. This suggests that the two 
phenomenons are related. The current prevalent 
hypothesis is to consider LCH a reactive process to 
neoplasms, particularly when associated with 
Hodgkin lymphoma, since both disease involves the 
same node concomitantly. This is also supported by 
the primary regression of LCH during treatment and 
the finding  of polyclonal Langerhans cells when 
associated with malignant neoplasms [2]. The 
proliferation of Langerhans cells could be linked to 
cytokines secreted by the inflammatory background 
cells of Hodgkin lymphoma.
Discussion
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Introduction
Case Report
Langerhans cell histiocytosis (LCH) is a 
clonal neoplastic proliferation of myeloid 
dendritic cells that upon activation migrate 
from the mucosal to lymph nodes. LCH is 
rarely, yet not exceptionally, found 
coexisting with other malignant neoplasms, 
suggesting it might arise in reaction to the 
cytokinic secretion of malignant cells.
A 10-year-old girl presented with a right 
laterocerv ical mass that had been 
progressing for two months. Anamnesis 
revealed a weight loss of approximately ten 
percent over the last few months, mild 
permanent diffuse sweating and vague chest 
pains. Laboratory studies revealed an 
inflammatory anemia associated with 
elevated ESR and LDH.  
Fig 1. Cervical lymphadenopathy biopsy revealed a fibronodular pattern of eosinophilic 
inflammatory cells surrounding a few Reed-Steenberg cells CD30+ associated with numerous 
Langerhans cells and histiocytes CD68 +.  
  
Fig. 2  Initial imaging by computed tomography showed bilateral jugular lymphadenopathy, a large 
mediastinal mass, multiples splenic nodules, and numerous mediastinal and lomboaortic 
lymphadenopathies.  
These elements pleaded for the diagnosis of 
scleronodular Hodgkin Lymphoma associated 
with LCH. The patient was treated according 
to the Euronet PHL C1 TL3 protocol. 
Response evaluation by PET-CT after six 
cycles of chemotherapy revealed complete 
remission. 
• Various neoplasms have been reported 
associated with LCH. Timing of occurrence is 
different for  LCH associated with lymphoma and 
leukemia, suggesting distinct mechanisms 
underlying these associations. 
• Practicians should be aware of the possibility of 
the combination of LCH with Hodgkin lymphoma, 
since both diseases can take the same clinical 
form, and yet have a very different prognosis. 
• Diagnosis of isolated LCH should be posed after 
exclusion of underlying more aggressive 
diseases.
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